Better-than-expected December quarter results and upbeat guidance at Alphabet (GOOGL), Amazon (AMZN), and others, are keeping investors in a positive mood as the December quarter earnings palooza continues today.
The following companies are expected to report earnings prior to market open on 02/03/2021. Visit our Earnings Calendar for a full list of expected earnings releases.AbbVie Inc. (ABBV) is reporting for the quarter ending December 31, 2020. The large cap pharmaceutical company's
The following companies are expected to report earnings after hours on 02/02/2021. Visit our Earnings Calendar for a full list of expected earnings releases.Amazon.com, Inc. (AMZN) is reporting for the quarter ending December 31, 2020. The internet company's consensus earnings p
Earnings for the October-December quarter are anticipated to have been better on a sequential basis as evident from the S&P 500’s expected earnings decline of 5.6% compared with fall of 7% recorded in the prior quarter. Also, revenue growth of 1% is expected for the S&P
Shares of Google parent Alphabet (GOOG , GOOGL) are up 4% year to date; ahead of its fourth quarter fiscal 2020 earnings results Tuesday, investors want to know if the gains are sustainable.
Investors will face a proverbial onslaught of quarterly earnings today, with several high-profile reports, including those from Amazon (AMZN) and Alphabet (GOOGL) after U.S. equity markets close today. And as they digest those results and guidance, investors will be keeping tabs
The following companies are expected to report earnings prior to market open on 02/02/2021. Visit our Earnings Calendar for a full list of expected earnings releases.Alibaba Group Holding Limited (BABA) is reporting for the quarter ending December 31, 2020. The internet company'
The following companies are expected to report earnings after hours on 02/01/2021. Visit our Earnings Calendar for a full list of expected earnings releases.Vertex Pharmaceuticals Incorporated (VRTX) is reporting for the quarter ending December 31, 2020. The biomedical (gene) co
The Auto sector has started this earnings season on a somewhat mixed note. Before delving into the factors that are likely to have shaped the quarterly results this time around, let’s take a look at the S&P auto sector components that have unveiled fourth-quarter results s
Fiscal stimulus hopium is likely to be rekindled today as the ten Senate Republicans who proposed a $600 billion stimulus compromise will meet with President Biden late this afternoon.
The excess volatility, compounded by worries about the slowness of the coronavirus vaccine rollout, could be a recipe for a selloff which some analysts believe has been long overdue.
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Fourth-quarter results of Medical Products companies within the broader Medical sector are expected to reflect strong rebound in procedure volume as a result of pent-up demand. This basically is the consequence of subdued consumer spending in the form of deferral of non-electiv
In addition to the latest earnings, economic, and coronavirus news, U.S. futures and investor confidence are feeling the weight of expected hedge fund short-covering in the wake of Robinhood Markets reinstating trading for select stocks, such as GameStop (GME).
The following companies are expected to report earnings prior to market open on 01/29/2021. Visit our Earnings Calendar for a full list of expected earnings releases.Eli Lilly and Company (LLY) is reporting for the quarter ending December 31, 2020. The large cap pharmaceutical
The following companies are expected to report earnings after hours on 01/28/2021. Visit our Earnings Calendar for a full list of expected earnings releases.Visa Inc. (V) is reporting for the quarter ending December 31, 2020. The financial transactions company's consensus earnin
The fourth-quarter earnings season for pharma stocks has started with Johnson & Johnson JNJ reporting encouraging results earlier this week. However, sales of another big pharma player, Novartis, which also reported earlier this week, were dampened as COVID-19 negatively impa